Results 221 to 230 of about 31,695,425 (269)

Asymmetric Structure‐Driven Functional Synergy: A Multistimuli‐Activated Janus Nanomotor for Self‐Amplifying NO Cascade Therapy

open access: yesAdvanced Science, EarlyView.
The Janus nanomotors leverage an “asymmetric structure‐driven functional synergy” strategy to orchestrate spatiotemporally coordinated catalytic functions, in situ self‐amplifying NO generation, and deep tumor penetration, thereby enabling controllable, sustained, and uniform NO generation within the tumor microenvironment.
Chengcheng Li   +6 more
wiley   +1 more source

Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis. [PDF]

open access: yesWorld J Hepatol, 2016
Correa CG   +10 more
europepmc   +1 more source

Association of insulin-like growth factor II mrna-binding protein 3 (IMP3) expression with prognostic and morphological factors in endometrial cancer [PDF]

open access: diamond
Silas Otero Reis Salum   +5 more
openalex   +1 more source

A Hepatocyte‐to‐Stellate Cell Axis Couples Alternate‐Day Fasting to Liver Fibrosis Resolution via ATG7 S‐Nitrosylation

open access: yesAdvanced Science, EarlyView.
Alternate‐day fasting suppresses mitochondrial complex II assembly via SDHAF4 to upregulate hepatocyte eNOS. The resulting nitric oxide S‐nitrosylates ATG7 at C184 in hepatic stellate cells, restraining autophagic flux and preventing their profibrotic activation.
Xueqiang Wang   +17 more
wiley   +1 more source

Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women.

open access: yesAnn Oncol, 2020
Murphy N   +10 more
europepmc   +1 more source

Insulin-like growth factor binding protein-3 links obesity and breast cancer progression. [PDF]

open access: yesOncotarget, 2016
Scully T   +7 more
europepmc   +1 more source

The utility of Insulin Like Growth Factor Binding Proteins (IGFBPs-1, 2, 3) with genes expression in resistance to Imatinib and Nilotinib in chronic myeloid leukemia: a pilot study from Delta Egypt

open access: diamond
Nadia El Menshawy   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy